Rao, Suchitra
Jing, Naimin
Liu, Xiaokang
Lorman, Vitaly
Maltenfort, Mitchell
Schuchard, Julia
Wu, Qiong
Tong, Jiayi
Razzaghi, Hanieh
Mejias, Asuncion
Lee, Grace M.
Pajor, Nathan M.
Schulert, Grant S.
Thacker, Deepika
Jhaveri, Ravi
Christakis, Dimitri A.
Bailey, L. Charles
Forrest, Christopher B.
Chen, Yong
Article History
Received: 22 June 2023
Accepted: 16 November 2023
First Online: 28 November 2023
Competing interests
: Dr. Mejias reports funding from Janssen, Merck for research support, and Janssen, Merck and Sanofi-Pasteur for Advisory Board participation; Dr. Rao reports prior grant support from GSK and Biofire. Dr. Chen receives consulting support from GSK. Dr. Jhaveri is a consultant for AstraZeneca, Seqirus and Dynavax, and receives an editorial stipend from Elsevier. All other authors have no conflicts of interest to disclose.